Cargando…
S25. COGNITIVE REMEDIATION THERAPY AND ITS EFFECTS ON BDNF SERUM LEVELS
BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been proposed as a biomarker of schizophrenia and, more specifically, as a biomarker of cognitive recovery. Unfortunately, it has only been tested once with cognitive remediation treatment (CRT). METHODS: A randomized and controlled trial (NCT...
Autores principales: | Penades, Rafael, López-Vílchez, Irene, Catalán, Rosa, Arias, Barbara, García-Rizo, Clemente, Masana, Guillem, Bernardo, Miquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888225/ http://dx.doi.org/10.1093/schbul/sby018.812 |
Ejemplares similares
-
The Integration of Cognitive Remediation Therapy into the Whole Psychosocial Rehabilitation Process: An Evidence-Based and Person-Centered Approach
por: Penadés, Rafael, et al.
Publicado: (2012) -
S245. BRAIN CONNECTIVITY CHANGES AFTER COGNITIVE REMEDIATION: A RESTING-STATE STUDY
por: Penadés, Rafael, et al.
Publicado: (2020) -
The role of genetics in cognitive remediation in schizophrenia: A systematic review
por: Penadés, Rafael, et al.
Publicado: (2019) -
Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review
por: Penadés, Rafael, et al.
Publicado: (2017) -
Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2015)